129 related articles for article (PubMed ID: 14528066)
1. Cutaneous hand and foot toxicity associated with cancer chemotherapy.
Childress J; Lokich J
Am J Clin Oncol; 2003 Oct; 26(5):435-6. PubMed ID: 14528066
[No Abstract] [Full Text] [Related]
2. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
Risum S; Langer SW
Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
[TBL] [Abstract][Full Text] [Related]
3. Palmar-plantar erythrodysesthesia.
Wilkes GM; Doyle D
Clin J Oncol Nurs; 2005 Feb; 9(1):103-6. PubMed ID: 15751504
[No Abstract] [Full Text] [Related]
4. Hand-foot syndrome.
Pike K
Oncol Nurs Forum; 2001; 28(10):1519-20. PubMed ID: 11759299
[No Abstract] [Full Text] [Related]
5. Periarticular Thenar Erythema and Onycholysis Syndrome: A Manifestation of Taxane-Induced Cutaneous Toxicity.
Rodríguez-Lomba E; Molina-López I; Suárez-Fernández R; Baniandrés-Rodríguez O
Actas Dermosifiliogr; 2017; 108(6):595-597. PubMed ID: 28117052
[No Abstract] [Full Text] [Related]
6. Hand-foot syndrome after dose-dense adjuvant chemotherapy for breast cancer: a case series.
Bardia A; Loprinzi CL; Goetz MP
J Clin Oncol; 2006 May; 24(13):e18-9. PubMed ID: 16648492
[No Abstract] [Full Text] [Related]
7. Flagellate erythema induced by docetaxel.
Tallon B; Lamb S
Clin Exp Dermatol; 2008 May; 33(3):276-7. PubMed ID: 18201264
[TBL] [Abstract][Full Text] [Related]
8. Dermatologic changes after systemic cancer therapy.
Nixon DW; Pirozzi D; York RM; Black M; Lawson DH
Cutis; 1981 Feb; 27(2):181-2, 186-8, 192-4. PubMed ID: 6164518
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous reaction associated with weekly docetaxel administration.
Chew L; Chuen VS
J Oncol Pharm Pract; 2009 Mar; 15(1):29-34. PubMed ID: 18753180
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs.
Reyes-Habito CM; Roh EK
J Am Acad Dermatol; 2014 Aug; 71(2):203.e1-203.e12; quiz 215-6. PubMed ID: 25037800
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil).
Hatam N; Ahmadloo N; Ahmad Kia Daliri A; Bastani P; Askarian M
Arch Gynecol Obstet; 2011 Jul; 284(1):215-20. PubMed ID: 20740365
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous reactions to chemotherapy drugs: the art of consultation.
Remlinger KA
Arch Dermatol; 2003 Jan; 139(1):77-81. PubMed ID: 12533171
[No Abstract] [Full Text] [Related]
13. Chemotherapy-induced toxic erythema under treatment with pegylated liposomal doxorubicin: No restriction to palms and soles.
Ziemer M; Goetze S; Kaatz M; Elsner P
J Am Acad Dermatol; 2008 Feb; 58(2 Suppl):S44-6. PubMed ID: 18191705
[No Abstract] [Full Text] [Related]
14. Palmar-plantar erythrodysaesthesia and non-pegylated liposomal doxorubicin. A case study.
Tamayo-Orbegozo E; Iruin-Sanz A; Oñate-Muzás E; Segrelles-Bellmunt G
Farm Hosp; 2011; 35(1):46-7. PubMed ID: 20619714
[No Abstract] [Full Text] [Related]
15. Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome.
Lokich JJ; Moore C
Ann Intern Med; 1984 Dec; 101(6):798-9. PubMed ID: 6497196
[No Abstract] [Full Text] [Related]
16. Toxic erythema of chemotherapy: a useful clinical term.
Bolognia JL; Cooper DL; Glusac EJ
J Am Acad Dermatol; 2008 Sep; 59(3):524-9. PubMed ID: 18694683
[No Abstract] [Full Text] [Related]
17. Severe palmar-plantar erythema in a patient with breast cancer receiving doxorubicin-cyclophosphamide chemotherapy.
Damasiewicz MJ; Chionh FJ; Hayes T
Intern Med J; 2007 Jul; 37(7):505-6. PubMed ID: 17547732
[No Abstract] [Full Text] [Related]
18. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.
Webster-Gandy JD; How C; Harrold K
Eur J Oncol Nurs; 2007 Jul; 11(3):238-46. PubMed ID: 17350337
[TBL] [Abstract][Full Text] [Related]
19. Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts.
von Moos R; Thuerlimann BJ; Aapro M; Rayson D; Harrold K; Sehouli J; Scotte F; Lorusso D; Dummer R; Lacouture ME; Lademann J; Hauschild A
Eur J Cancer; 2008 Apr; 44(6):781-90. PubMed ID: 18331788
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histopathologic correlation of an eruption secondary to Taxotere.
Beer K; Oakley H
J Drugs Dermatol; 2010 Dec; 9(12):1534-5. PubMed ID: 21120264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
